Anil Ananthaneni

424 total citations
27 papers, 245 citations indexed

About

Anil Ananthaneni is a scholar working on Pharmacology, Hematology and Immunology. According to data from OpenAlex, Anil Ananthaneni has authored 27 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Hematology and 5 papers in Immunology. Recurrent topics in Anil Ananthaneni's work include Drug-Induced Adverse Reactions (4 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers) and Psychosomatic Disorders and Their Treatments (2 papers). Anil Ananthaneni is often cited by papers focused on Drug-Induced Adverse Reactions (4 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers) and Psychosomatic Disorders and Their Treatments (2 papers). Anil Ananthaneni collaborates with scholars based in United States, India and United Kingdom. Anil Ananthaneni's co-authors include Dean F. Wong, James Robert Brašić, Yun Zhou, Tatyana Verina, Mohab Alexander, Tomás R. Guilarte, Robert J. Adams, Hiroto Kuwabara, Jennifer L. McGlothan and Ming‐Kai Chen and has published in prestigious journals such as Blood, NeuroImage and CHEST Journal.

In The Last Decade

Anil Ananthaneni

21 papers receiving 235 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anil Ananthaneni United States 8 76 75 27 24 23 27 245
Luigi Carlo Bottaro Italy 9 75 1.0× 38 0.5× 27 1.0× 9 0.4× 45 2.0× 23 297
Ajit Kumar India 12 89 1.2× 33 0.4× 32 1.2× 18 0.8× 27 1.2× 32 358
M. Boussac-Zarebska France 8 120 1.6× 51 0.7× 5 0.2× 24 1.0× 32 1.4× 10 324
Johnathan A. Edwards United States 8 113 1.5× 27 0.4× 128 4.7× 15 0.6× 31 1.3× 21 357
Elliot Lass Canada 8 161 2.1× 29 0.4× 4 0.1× 57 2.4× 44 1.9× 12 304
Fabio Cruciani Italy 12 28 0.4× 26 0.3× 10 0.4× 13 0.5× 43 1.9× 41 437
Yasaman Emami Iran 9 57 0.8× 15 0.2× 91 3.4× 5 0.2× 44 1.9× 17 347
Mohammed F. Islam United States 10 248 3.3× 10 0.1× 57 2.1× 41 1.7× 40 1.7× 24 463
Wallace Jones United States 5 70 0.9× 40 0.5× 3 0.1× 18 0.8× 20 0.9× 7 251
Zoya Zaeem Canada 5 62 0.8× 30 0.4× 3 0.1× 13 0.5× 8 0.3× 9 221

Countries citing papers authored by Anil Ananthaneni

Since Specialization
Citations

This map shows the geographic impact of Anil Ananthaneni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anil Ananthaneni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anil Ananthaneni more than expected).

Fields of papers citing papers by Anil Ananthaneni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anil Ananthaneni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anil Ananthaneni. The network helps show where Anil Ananthaneni may publish in the future.

Co-authorship network of co-authors of Anil Ananthaneni

This figure shows the co-authorship network connecting the top 25 collaborators of Anil Ananthaneni. A scholar is included among the top collaborators of Anil Ananthaneni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anil Ananthaneni. Anil Ananthaneni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jain, Saurabh, et al.. (2025). TCL-1291: Atypical Relapse of Extranodal NK/T-Cell Lymphoma With Cardiac and Adrenal Involvement. Clinical Lymphoma Myeloma & Leukemia. 25. S881–S881.
2.
Ananthaneni, Anil, et al.. (2024). Impact of scheduled partial exchange transfusions on outcomes in pregnant patients with severe sickle cell disease: a retrospective study. Hematology Transfusion and Cell Therapy. 46. S109–S114. 1 indexed citations
3.
Al‐Yafeai, Zaki, et al.. (2024). Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS). International Journal of Cardiology. 402. 131819–131819. 10 indexed citations
4.
Ananthaneni, Anil, et al.. (2024). Thrombotic thrombocytopenic purpura in a patient with adult-onset Still’s disease: report of a rare entity. BMJ Case Reports. 17(11). e260691–e260691.
5.
6.
Ananthaneni, Anil, et al.. (2023). Evaluation of Flow Rate, pH, and Buffering Capacity of Saliva in Children with Caries, Fluorosis, and Caries with Fluorosis. International Journal of Clinical Pediatric Dentistry. 16(4). 587–590. 4 indexed citations
7.
8.
9.
Ananthaneni, Anil, et al.. (2023). Immunosuppressant Drug-Associated Non-Hodgkin Lymphoma: A Real-World Pharmacovigilance Database Analysis. Blood. 142(Supplement 1). 6268–6268. 2 indexed citations
10.
Al‐Yafeai, Zaki, et al.. (2022). Cardiovascular complications of modern multiple myeloma therapy: A pharmacovigilance study. British Journal of Clinical Pharmacology. 89(2). 641–648. 14 indexed citations
11.
Ananthaneni, Anil, et al.. (2020). Efficacy of Tranexamic Acid in Reducing Blood Loss in Lower Segment Cesearean Section: A Randomised Controlled Study. The Journal of Obstetrics and Gynecology of India. 70(6). 479–484. 9 indexed citations
12.
Ananthaneni, Anil, et al.. (2020). Aspergillus Mimicking a Rasmussen Aneurysm in an Immunocompromised Setting Causing Massive Hemoptysis. Infectious Diseases in Clinical Practice. 28(5). 261–271.
13.
Ananthaneni, Anil, et al.. (2019). Mobile Health for Tuberculosis Management in South India: Is Video-Based Directly Observed Treatment an Acceptable Alternative?. JMIR mhealth and uhealth. 7(4). e11687–e11687. 36 indexed citations
14.
Goruntla, Narayana, et al.. (2019). Knowledge, Attitude and Practice of Community Pharmacists on Medication Safety during Pregnancy: A Cross-sectional Study. International Journal of Pharmaceutical Investigation. 9(4). 215–219. 1 indexed citations
15.
Narayanappa, D., et al.. (2013). Clinico-bacteriological profile and outcome of empyema. Indian Pediatrics. 50(8). 783–785. 23 indexed citations
16.
Wong, Dean F., Susanne Ostrowitzki, Yun Zhou, et al.. (2011). Characterization of [11C]RO5013853, a novel PET tracer for the glycine transporter type 1 (GlyT1) in humans. NeuroImage. 75. 282–290. 17 indexed citations
17.
Chen, Ming‐Kai, Hiroto Kuwabara, Yun Zhou, et al.. (2007). VMAT2 and dopamine neuron loss in a primate model of Parkinson’s disease. Journal of Neurochemistry. 105(1). 78–90. 95 indexed citations
18.
Ananthaneni, Anil, et al.. (2001). Relationship between Team Structure and Interprofessional Working at a Medium Secure Unit for People with Learning Disabilities in the United Kingdom. Research Explorer (The University of Manchester). 5(4). 319–329. 2 indexed citations
19.
Ananthaneni, Anil & Meena Agarwal. (1996). DISCHARGE PROSPECTS OF A MENTAL HANDICAP POPULATION: A SURVEY OF NURSING PERCEPTIONS. The British Journal of Development Disabilities. 42(82). 63–69. 1 indexed citations
20.
Agarwal, Meena & Anil Ananthaneni. (1994). Mental Health Review Tribunals. Psychiatric Bulletin. 18(10). 649–650. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luigi Carlo Bottaro Breakdown of academic impact, for papers by Ajit Kumar Breakdown of academic impact, for papers by M. Boussac-Zarebska Breakdown of academic impact, for papers by Johnathan A. Edwards Breakdown of academic impact, for papers by Elliot Lass Breakdown of academic impact, for papers by Fabio Cruciani Breakdown of academic impact, for papers by Yasaman Emami Breakdown of academic impact, for papers by Mohammed F. Islam Breakdown of academic impact, for papers by Wallace Jones Breakdown of academic impact, for papers by Zoya Zaeem
Rankless by CCL
2026